A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia

Gabriella Silvestri, Enzo Ricci, Nicola Montano, Mario Sabatelli, Marco Luigetti, Anna Modoni, Rosaria Renna, Giordano Tasca, Manuela Papacci, Mauro Monforte, Amelia Conte

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous neuropathies classically divided into demyelinating (CMT1) and axonal forms (CMT2). The most common demyelinating form is CMT1A, due to a duplication in the gene encoding the peripheral myelin protein 22 (PMP22). Less frequently, mutations in the myelin protein zero gene (MPZ/P0) account for demyelinating CMT1B. Herein, we report a patient presenting with an isolated hyperCKemia in whom electrophysiological and pathological findings revealed a demyelinating and axonal neuropathy. Sequencing of the MPZ gene revealed a 306delA at codon 102 in the proband and in two relatives. This mutation has been already described in association with paucisymptomatic CMT without hyperCKemia.
Original languageEnglish
Pages (from-to)794-797
Number of pages4
JournalClinical Neurology and Neurosurgery
Publication statusPublished - 2010


  • Action Potentials
  • Adult
  • Axons
  • Biopsy
  • Charcot-Marie-Tooth Disease
  • Codon
  • Creatine Kinase
  • Diagnosis
  • Electromyography
  • Family
  • Genetic Testing
  • Humans
  • Male
  • Motor Neurons
  • Mutation
  • Myelin P0 Protein
  • Neural Conduction
  • Neurologic Examination
  • Peripheral Nerves
  • Sensory Receptor Cells


Dive into the research topics of 'A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia'. Together they form a unique fingerprint.

Cite this